Joslin Diabetes Center

The Joslin Diabetes Center is a hospital and research center for the research and treatment of diabetes mellitus is based in Boston. It is named after its founder Elliott P. Joslin, arising from the 1898 diabetes practice, it emerged that later evolved into a group practice and was equipped from 1934 with research laboratories. In 1952 the establishment was called the Joslin Clinic, in 1981 it was renamed the Joslin Diabetes Center. The device, which is often referred to in the United States by patients and doctors as " the Joslin ", one of the leading institutions worldwide in the field of diabetes treatment and research.

The Joslin Diabetes Center has approximately 600 employees and is associated as a teaching hospital with the medical faculty of Harvard University. It is divided into three areas: Joslin Clinic for the treatment of patients Joslin Research for research activities and Joslin Strategic Initiatives for the development and commercialization of products, services and educational programs for patients and physicians. This area of ​​research, which brings together some 40 working group leaders and more than 300 employees, has an annual budget of around 40 million U.S. dollars.

The focus of research at the Joslin Diabetes Center are the biochemical and genetic basis of development of diabetes mellitus and its late complications. In clinical applications, it is particularly focused on the treatment of children and adolescents with diabetes, to the care of diabetic mothers during pregnancy and for the treatment of diabetes-related complications. The number of patients is at about 23,000 per year.